Vienna, Austria

Boris Ferko

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Boris Ferko

Introduction

Boris Ferko is a notable inventor based in Vienna, Austria. He has made significant contributions to the fields of medicine and virology, particularly through his innovative patents. With a total of two patents to his name, Ferko's work focuses on the prevention and treatment of infectious and oncological diseases.

Latest Patents

Ferko's latest patents include "Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases." This invention relates to the development of an attenuated influenza A virus, which serves as a vector for delivering therapeutic agents. The pharmaceutical composition derived from this invention can be utilized for both the prevention and treatment of infectious diseases. Additionally, he has developed a novel influenza virus that modifies the NS and PB1 gene segments, resulting in a virus lacking functional NS1 and PB1-F2 proteins. This innovation also includes a vaccine formulation aimed at preventing influenza.

Career Highlights

Throughout his career, Boris Ferko has worked with various companies, including Pharmenterprises Biotech Limited Liability Company and Nanotherapeutics, Inc. His experience in these organizations has contributed to his expertise in biotechnology and pharmaceutical development.

Collaborations

Ferko has collaborated with notable professionals in his field, including Andrei Yurievich Egorov and Artem Alexandrovich Krokhin. These collaborations have likely enhanced his research and development efforts.

Conclusion

Boris Ferko's contributions to the field of medicine through his innovative patents demonstrate his commitment to advancing healthcare solutions. His work in developing attenuated influenza vectors and novel influenza viruses highlights the importance of innovation in combating infectious and oncological diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…